Traditional Chinese medicine decoction piece combined preparation containing Jin Gu Lian Pian, preparation method and combined package

Abstract

The invention discloses a traditional Chinese medicine decoction piece combined preparation containing Jin Gu Lian Pian, a preparation method and a combined package. The traditional Chinese medicine decoction piece combined preparation containing the Jin Gu Lian Pian comprises raw materials in parts by weight as follows: 343 parts of gaultheria yunnanensis, 400 parts of schefflera kwangsiensis, 370 parts of caulis sargentodoxae, 50 parts of Chinese alangium root and 50 parts of psammosilene tunicoides. The traditional Chinese medicine decoction piece combined preparation containing the Jin Gu Lian Pian has functions of dispelling wind, eliminating dampness and relieving swelling and pain, is used for treating joint gall, difficulty in flexion and extension and the like caused by rheumatism blockage stasis, is good in curative effect and free of toxic and side effects, and takes effect quickly.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine

Login to view more

AI Technical Summary

Benefits of technology

This patented new type medicinal composition called Yujiaolintan Tablettage (YJT) contains certain ingredients that help reduce inflammation on skin when applied topically. These compositions have several advantages such as being able to stop bleeding easily during dressings, having long lasting efficacy over multiple hours, reducing symptoms faster than existing methods like cold packs, pills, bone fillers, and other forms of remedies. They also provide relief against lumbago due to excessive weight loss while maintain their therapeutic benefits.

Problems solved by technology

This patents discusses methods aimed towards finding new ways to manage rheaematosity associated conditions like chronicity spontancies, lymphopenia syndrome, renal failure due to alcohol abuse, severe asthma attacks, bone degenerating processes involving connectivity within specific parts called nerve fibers and cell bodies involved in inflamed areas. These technical problem addressed during development of novel medical products targeting these issues needs is developing improved methodologies for identifying suitable targets for optimal therapies while minimizing negative responses from each component.